XML 54 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Equity (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of reconciliation of common stock share activity

(Shares of common stock, in thousands)

Issued

Held in Treasury

Outstanding

 

Balance at December 31, 2017

77,811

5,815

71,996

Issuance of restricted stock units as compensation

(100)

100

Performance shares and other share-based awards

(68)

68

Stock options exercised

(209)

209

Purchase/acquisition of treasury stock

5,847

(5,847)

Balance at December 31, 2018

77,811

11,285

66,526

Issuance of restricted stock units as compensation

(105)

105

Performance shares and other share-based awards

(5)

5

Stock options exercised

(182)

182

Purchase/acquisition of treasury stock

Balance at December 31, 2019

77,811

10,993

66,818

Issuance of restricted stock units as compensation

(69)

69

Performance shares and other share-based awards

(5)

5

Stock options exercised

(124)

124

Purchase/acquisition of treasury stock

Balance at December 31, 2020

77,811

10,795

67,016

Schedule of stock based compensation expense

(in millions)

 

2020

    

2019

    

2018

 

Stock options:

Pre-tax compensation expense

$

4

 

$

3

 

$

5

Income tax benefit

 

 

 

(1)

Stock option expense, net of income taxes

 

4

 

3

 

4

Restricted stock units ("RSUs"):

Pre-tax compensation expense

 

12

 

10

 

12

Income tax benefit

 

(1)

 

(2)

 

(2)

RSUs, net of income taxes

 

11

 

8

 

10

Performance shares and other share-based awards:

Pre-tax compensation expense

 

7

 

5

 

4

Income tax benefit

 

(1)

 

 

Performance shares and other share-based compensation expense, net of income taxes

 

6

 

5

 

4

Total share-based compensation:

Pre-tax compensation expense

 

23

 

18

 

21

Income tax benefit

 

(2)

 

(2)

 

(3)

Total share-based compensation expense, net of income taxes

$

21

 

$

16

 

$

18

Schedule of valuation assumptions for stock options

For the Year Ended December 31,

2020

2019

2018

Expected life (in years)

5.5

5.5

5.5

Risk-free interest rate

1.4

%  

2.5

%  

2.5

%

Expected volatility

19.8

%  

19.7

%  

19.8

%

Expected dividend yield

2.9

%  

2.7

%  

1.8

%

Schedule of stock option transactions

    

Number of Options (in thousands)

    

Weighted Average Exercise Price per Share

    

Average Remaining Contractual Term (Years)

    

Aggregate Intrinsic Value (in millions)

 

Outstanding as of December 31, 2019

 

2,055

 

$

84.36

5.30

$

34

Granted

 

336

88.35

Exercised

 

(124)

47.12

Cancelled

 

(29)

103.57

Outstanding as of December 31, 2020

 

2,238

$

86.55

 

5.15

 

$

14

Exercisable as of December 31, 2020

 

1,709

$

84.38

 

4.11

 

$

14

Schedule of additional information pertaining to stock option activity

Year Ended December 31, 

(dollars in millions, except per share)

  

2020

    

2019

2018

Weighted average grant date fair value of stock options granted (per share)

$

11.48

$

14.02

$

24.01

Total intrinsic value of stock options exercised

5

10

15

Summary of net changes in accumulated other comprehensive loss

(in millions)

    

Cumulative Translation Adjustment

    

Deferred (Loss) Gain on Hedging Activities

    

Pension and Postretirement Adjustment

    

Unrealized (Loss) Gain on Investment

    

Accumulated Other Comprehensive Loss

   

Balance, December 31, 2017

$

(951)

$

(13)

$

(51)

$

2

$

(1,013)

Other comprehensive income (loss) before reclassification adjustments

(129)

8

(20)

(141)

Amount reclassified from accumulated OCI

6

6

Tax benefit (provision)

(4)

5

1

Net other comprehensive income (loss)

(129)

10

(15)

(134)

Adoption of ASU 2016-01

(2)

(2)

Adoption of ASU 2018-02

(2)

(3)

(5)

Other

(2)

(3)

(2)

(7)

Balance, December 31, 2018

(1,080)

(5)

(69)

(1,154)

Other comprehensive (loss) income before reclassification adjustments

(9)

(19)

11

(17)

Amount reclassified from accumulated OCI

14

14

Tax benefit (provision)

1

(2)

(1)

Net other comprehensive (loss) income

(9)

(4)

9

(4)

Balance, December 31, 2019

$

(1,089)

$

(9)

$

(60)

$

$

(1,158)

Other comprehensive loss before reclassification adjustments

(25)

5

(2)

(22)

Amount reclassified from accumulated OCI

65

65

Tax benefit (provision)

(19)

1

(18)

Net other comprehensive loss

(25)

51

(1)

25

Balance, December 31, 2020

$

(1,114)

$

42

$

(61)

$

$

(1,133)

Schedule of basic and diluted earnings per common share

2020

2019

2018

Net Income

Weighted

Per

Net Income

Weighted

Per

Net Income

Weighted

Per

Available

Average

Share

Available

Average

Share

Available

Average

Share

(in millions, except per share amounts)

    

to Ingredion

  

Shares

  

Amount

  

to Ingredion

  

Shares

  

Amount

  

to Ingredion

  

Shares

  

Amount

Basic EPS

$

348

 

67.2

$

5.18

$

413

 

66.9

$

6.17

$

443

 

70.9

$

6.25

Effect of Dilutive Securities:

Incremental shares from assumed exercise of dilutive stock options and vesting of dilutive RSUs and other awards

 

0.4

 

0.5

 

0.9

Diluted EPS

$

348

 

67.6

$

5.15

$

413

 

67.4

$

6.13

$

443

 

71.8

$

6.17

Restricted stock units (RSUs) | Employee  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of restricted unit activity

Weighted

Number of

Average

Restricted

Fair Value

(shares in thousands)

Shares

per Share

Non-vested at December 31, 2019

339

$

108.02

Granted

196

87.01

Vested

(94)

117.33

Cancelled

(23)

101.72

Non-vested at December 31, 2020

418

$

96.45